ANALYSIS OF ASXL1 MUTATIONS AND CORRELATION WITH CHROMOSOMAL ALTERATIONS IN ACUTE MYELOID LEUKEMIA

被引：0

作者：

Kakosaiou, K. ^{[1
]}

Daraki, A. ^{[1
]}

Apostolou, P. ^{[1
]}

Zachaki, S. ^{[1
]}

Pagoni, M. ^{[2
]}

Sambani, C. ^{[1
]}

Dimitriadis, G. ^{[3
]}

Pappa, V. ^{[3
]}

Manola, K. ^{[1
]}

机构：

[1] NCSR DEMOKRITOS, Athens, Greece

[2] Evangelismos Med Ctr, Athens, Greece

[3] Univ Gen Hosp Attikon, Athens, Greece

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

E903

引用

页码：359 / 360

页数：2

共 50 条

[31] The role of ASXL1 mutations and ASXL1 CircRNAs in cancer
Jafarbeik-Iravani, Narges
Kolahdozan, Sara
Esmaeili, Rezvan
BIOMARKERS, 2024, 29 (01) : 1 - 6
[32] Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
N Carbuccia
V Trouplin
V Gelsi-Boyer
A Murati
J Rocquain
J Adélaïde
S Olschwang
L Xerri
N Vey
M Chaffanet
D Birnbaum
M J Mozziconacci
Leukemia, 2010, 24 : 469 - 473
[33] ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
Lioba Schönfeld
Jenny Rinke
Anna Hinze
Saskia N. Nagel
Vivien Schäfer
Thomas Schenk
Christian Fabisch
Tim H. Brümmendorf
Andreas Burchert
Philipp le Coutre
Stefan W. Krause
Susanne Saussele
Fatemeh Safizadeh
Markus Pfirrmann
Andreas Hochhaus
Thomas Ernst
Leukemia, 2022, 36 : 2242 - 2249
[34] Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
Carbuccia, N.
Trouplin, V.
Gelsi-Boyer, V.
Murati, A.
Rocquain, J.
Adelaide, J.
Olschwang, S.
Xerri, L.
Vey, N.
Chaffanet, M.
Birnbaum, D.
Mozziconacci, M. J.
LEUKEMIA, 2010, 24 (02) : 469 - 473
[35] Allogeneic hematopoietic stem cell transplantation could improve the survival of acute myeloid leukemia patients with ASXL1 mutations
Zhou, Lili
An, Jingnan
Hou, Chang
Ding, Zixuan
Qiu, Huiying
Tang, Xiaowen
Sun, Aining
Chen, Suning
Xu, Yang
Liu, Tianhui
Wu, Depei
HEMATOLOGY, 2021, 26 (01) : 340 - 347
[36] ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia
Schoenfeld, Lioba
Rinke, Jenny
Hinze, Anna
Nagel, Saskia N.
Schaefer, Vivien
Schenk, Thomas
Fabisch, Christian
Bruemmendorf, Tim H.
Burchert, Andreas
le Coutre, Philipp
Krause, Stefan W.
Saussele, Susanne
Safizadeh, Fatemeh
Pfirrmann, Markus
Hochhaus, Andreas
Ernst, Thomas
LEUKEMIA, 2022, 36 (09) : 2242 - 2249
[37] PROGNOSTIC VALUE OF MUTATIONS IN ASXL1 IN CHRONIC MYELOMONOCYTIC LEUKEMIA
Almorox Rebeca, Bailen
Gonzalez Julia, Suarez
Carolina, Martinez-Laperche
Noemi, Fernandez-Escalada
Maria, Chicano-Lavilla
Diego, Carbonell
Patricia, Font
Santiago, Osorio
Jose Lui, Diez-Martin
Ismael, Buno
HAEMATOLOGICA, 2016, 101 : 153 - 154
[38] Cooperative Effect of Haploinsufficient ASXL1 and NF1 in Acute Myeloid Leukemia Transformation
Zhang, Peng
Yamamoto, Shohei
Chen, Shi
Zhou, Yuan
Xu, Mingjiang
Yang, Feng-Chun
BLOOD, 2015, 126 (23)
[39] ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia
Shivarov, Velizar
Gueorguieva, Ralitza
Ivanova, Milena
Tiu, Ramon V.
LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1881 - 1883
[40] ASXL1 Mutations Are Associated with Widespread and Distinct DNA Methylation Alterations
Rahmani, Nora E.
Ramachandra, Nandini
Bhagat, Tushar D.
Gordon, Shanisha
Pradhan, Kith
Pena, Bianca Rivera
Kazemi, Mohammad
Giricz, Orsi
Maqbool, Shahina
Olea, Raul
Dolatshad, Hamid
Tittrea, Vickram
Tatwavedi, Dharamveer
Singh, Shalini
Pellagatti, Andrea
Boultwood, Jacqueline
Verma, Amit
BLOOD, 2019, 134

← 1 2 3 4 5 →